Clinical trial

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

NCT03043599

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-02-13

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2017-02-13Date precision: day

Registry last updated2024-12-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancerunresolved

Extensive-stage Small Cell Lung Cancerunresolved

Interventions

Thoracic Radiation TherapyRADIATION

IpilimumabDRUG · verified · RxNorm: ipilimumab

NivolumabDRUG · verified · RxNorm: nivolumab

Sponsors & collaborators

H. Lee Moffitt Cancer Center and Research Institutelead sponsor

Bristol-Myers Squibbcollaborator

Mapped research locations

TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03043599 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.